NYSE:PRLBProto Labs Stock Price, Forecast & News

Proto Labs' stock was trading at $78.36 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, PRLB shares have increased by 61.1% and is now trading at $126.26. View which stocks have been most impacted by Coronavirus.

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Proto Labs in the last year. There are currently 6 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Proto Labs.

Proto Labs is scheduled to release its next quarterly earnings announcement on Thursday, July 23rd 2020. View our earnings forecast for Proto Labs.

Proto Labs Inc (NYSE:PRLB) issued its quarterly earnings results on Thursday, April, 30th. The industrial products company reported $0.61 earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of $0.38 by $0.23. The industrial products company had revenue of $115.10 million for the quarter, compared to analyst estimates of $102.36 million. Proto Labs had a return on equity of 10.82% and a net margin of 13.49%. Proto Labs's revenue for the quarter was up 1.4% compared to the same quarter last year. During the same quarter last year, the business posted $0.69 EPS. View Proto Labs' earnings history.

7 Wall Street analysts have issued 12 month price objectives for Proto Labs' stock. Their forecasts range from $69.00 to $145.00. On average, they expect Proto Labs' share price to reach $94.50 in the next year. This suggests that the stock has a possible downside of 25.2%. View analysts' price targets for Proto Labs.

Headlines about PRLB stock have trended somewhat positive recently, InfoTrie reports. The research firm identifies positive and negative press coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Proto Labs earned a coverage optimism score of 1.7 on InfoTrie's scale. They also assigned news coverage about the industrial products company a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an effect on the company's share price in the next few days. View the latest news aboutProto Labs.

Proto Labs saw a decline in short interest during the month of May. As of May 15th, there was short interest totaling 4,610,000 shares, a decline of 5.3% from the April 30th total of 4,870,000 shares. Based on an average daily volume of 296,700 shares, the short-interest ratio is currently 15.5 days. Currently, 18.3% of the company's stock are short sold. View Proto Labs' Current Options Chain.

Some companies that are related to Proto Labs include Illinois Tool Works (ITW), Parker-Hannifin (PH), Stanley Black & Decker (SWK), Dover (DOV), Ingersoll-Rand (IR), Xylem (XYL), IDEX (IEX), Nordson (NDSN), Graco (GGG), Snap-on (SNA), Pentair (PNR), Gardner Denver (GDI), Donaldson (DCI), ITT (ITT) and Lincoln Electric (LECO). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Proto Labs investors own include Brainstorm Cell Therapeutics (BCLI), Netflix (NFLX), Tesla (TSLA), NVIDIA (NVDA), Starbucks (SBUX), Walt Disney (DIS), Gilead Sciences (GILD), Intel (INTC), Baidu (BIDU) and Alphabet (GOOG).

Proto Labs trades on the New York Stock Exchange (NYSE) under the ticker symbol "PRLB."

Proto Labs' stock is owned by many different institutional and retail investors. Top institutional shareholders include BlackRock Inc. (15.27%), Brown Capital Management LLC (14.22%), Riverbridge Partners LLC (5.65%), Sumitomo Mitsui Trust Holdings Inc. (4.62%), Nikko Asset Management Americas Inc. (4.62%) and Nikko Asset Management Americas Inc. (4.62%). Company insiders that own Proto Labs stock include Arthur R Baker III, John B Goodman, John Way, Robert Bodor and Sven Wehrwein. View institutional ownership trends for Proto Labs.

PRLB stock was sold by a variety of institutional investors in the last quarter, including Janus Henderson Group PLC, TimesSquare Capital Management LLC, BlackRock Inc., Motley Fool Asset Management LLC, Disciplined Growth Investors Inc. MN, Gs Investments Inc., Arizona State Retirement System, and Principal Financial Group Inc.. View insider buying and selling activity for Proto Labs.

PRLB stock was purchased by a variety of institutional investors in the last quarter, including Nikko Asset Management Americas Inc., Nikko Asset Management Americas Inc., Sumitomo Mitsui Trust Holdings Inc., State Street Corp, Morgan Stanley, Morgan Stanley, Aviva PLC, and Geode Capital Management LLC. View insider buying and selling activity for Proto Labs.

Shares of PRLB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of PRLB stock can currently be purchased for approximately $126.26.

Proto Labs has a market capitalization of $3.36 billion and generates $458.73 million in revenue each year. The industrial products company earns $63.65 million in net income (profit) each year or $2.35 on an earnings per share basis. Proto Labs employs 2,535 workers across the globe.

The official website for Proto Labs is www.protolabs.com.

Proto Labs' mailing address is 5540 Pioneer Creek Drive, Maple Plain MN, 55359. The industrial products company can be reached via phone at 763-479-3680 or via email at [email protected]